Acasti Pharma Cash Flow - Quarterly (NASDAQ:ACST)

Add to My Stocks
$0.72 $0.03 (4%) ACST stock closing price Jun 22, 2018 (Closing)

The financial analysis of ACST requires an investor to check the cash flows for Acasti Pharma. The profit-loss statement shows Acasti Pharma profits, the balance sheet shows Acasti Pharma debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Acasti Pharma had cash and cash equivalents of $1.15M at beginning of the quarter and $8.06M at quarter end of 2017 Q1. Acasti Pharma cash flow analysis tells whether or not the company has enough cash for its day to day activities, and for investing for future growth. Acasti Pharma has a positive cash and cash equivalents change of $5.75M.

View and download details of Acasti Pharma cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-7.99M-5.93M-4.22M-2.42M-4.84M-3.33M
Depreciation Depletion Amortization Cash-Flow1.91M1.38M--1.83M1.35M
Net Increase (Decrease) in Assets Liabilities-----0.03M-
Cash From (used in) Discontinued Operations------
Other Adjustments Net-----2M-2.11M
Net Cash from (used by) Operating Activities
-4.73M-3.6M-2.29M-1.59M-5.04M-3.69M
Increase (Decrease) in Prop Plant And Equipment-1.9M-1.33M-0.81M-0.39M-0.21M-0.16M
Acquisition Disposition of Subsidiaires------
Increase (Decrease) in Investments7.06M3.94M3.04M-6.5M6.4M
Other Cash Inflow (Outflow) from Investment Activities------
Net Cash from (used by) Investment Activities
5.26M2.69M2.24M-6.31M6.24M
Issuance (Purchase) of Equity Shares5.28M-----
Issuance (Repayment) of Debt Securities------
Increase (Decrease) in Bank & Other Borrowings------
Payment of Dividends & Other Cash Distributions------
Other Cash from (used by) Financing Activities-0.01M-0.01M-0.01M-0.01M--
Net Cash from (used by) Financing Activities
5.26M-0.01M-0.01M-0.01M--
Effect of Exchange Rate Changes on Cash-0.04M--0.03M-0.05M--
Net Change in Cash & Cash Equivalents
5.75M-0.91M-0.1M-1.25M1.31M2.6M
Cash & Equivalents at Beginning of Year1.15M-----
Cash & Equivalents at Year End8.06M1.36M2.22M1.06M2.32M3.59M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Acasti Pharma stock comparison chart provides an easy way to compare the stock price with peers along with details of Acasti Pharma stock price history.
The statement of cash flows can be categorized into the following main sections:

  • Acasti Pharma saw a positive change in Net Change in Cash and Cash Equivalents of $5.75M till 2017 Q1. Apart from the Acasti Pharma stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Acasti Pharma reported a negative operating cash flow of $-4.73M till 2017 Q1 and has seen a decrease from the previous quarter. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Growth companies, typically most tech companies; spend heavily on investing activities and this figure stood at $5.26M for ACST stock. Sometimes a company might have a negative overall cash flow which may not be really bad if it is due to investment expenses. Hence it is important to check the cash flow from investment activities.
  • Cash flow from financing activities shows the flow of cash between Acasti Pharma and its owners and creditors and was $5.26M till 2017 Q1. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For Acasti Pharma Cash Flow

FCF margin
0